XM does not provide services to residents of the United States of America.

U.S. stocks weekly: Dunked



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BUZZ-U.S. stocks weekly: Dunked</title></head><body>

** S&P 500 .SPX loses 2.1% as Powell douses hopes for Dec rate cut .N

** Weakness sets in just as SPX nears big barrier just above 6k; indeed, bulls suddenly in no hurry as post-election rally stalls

** Nasdaq composite .IXIC races to new highs, and for once, not gasping for "breadth," but then reverses; by Fri, Nasdaq advance/decline line hits new lows, IXIC ends down 3.1% for the week

** Nearly all sectors take a plunge: Healthcare drenched most, while just Energy and Financials stay afloat

** Healthcare .SPXHC plummets 5.5%. Drugmakers extend declines after Trump picks RFK Jr to lead top US health agency. Vaccine maker Moderna MRNA.O sheds 21% on week

AbbVie ABBV.N declines as schizophrenia drug fails in mid-stage studies

For the week, Nasdaq Biotech index .NBI sinks 10%

** Materials .SPLRCM melt 3.3%. Might gold's XAU= recent stumble turn into a real tumble? ARCA gold bugs index .HUI craters ~8%

** Tech .SPLRCT descends 3.2%. Applied Materials AMAT.O falls as fiscal Q1 rev forecast signals weak spending outside AI chips

Semiconductor index .SOX submerges nearly 9%

** Industrials .SPLRCI sag 2.1%. Defense, government contractor stocks extend recent slide as investors eye Trump's proposed DOGE (Department of Government Efficiency). Leidos LDOS.N and General Dynamics GD.N fall 19% and 7%, respectively, on the week

S&P 500 Aerospace & Defense index .SPLRCAERO loses 5%

** Communication Services .SPLRCL slip 2.1%. Though Disney DIS.N jumps and is top SPX performer as 'Deadpool & Wolverine' stars in quarterly beat. DIS notches 16.2% weekly gain for best such showing in 24 years

** Consumer Discretionary .SPLRCD dips 1.1%. Though Home Depot HD.N up after forecasting smaller drop in annual same-store sales

And Coach parent Tapestry TPR.N hits over decade-high after pulling $8.5 bln deal for Capri CPRI.N

** Financials .SPSY climb 1.4%. Charles Schwab SCHW.N gains on strong client asset growth in October

** Meanwhile, Bitcoin BTC= soars above $90,000 as it extends post-election gains, amid volume surge

** SPX performance YTD:


Financials

32.3%

Comm Svcs

32.1%

Tech

31.8%

Utils

24.7%

SPX

23.1%

Industrials

21.7%

Discretionary

21.4%

Staples

12.9%

Energy

12.8%

Real Estate

7.0%

Materials

6.3%

Healthcare

3.9%



(Lance Tupper and Terence Gabriel are Reuters market analysts. The views expressed are their own)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.